Citadel Advisors’s Purple Biotech PPBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,231
| Closed | -$10.2K | – | 6485 |
|
|
2024
Q2 | $10.2K | Sell |
1,231
-1,670
| -58% | -$13.9K | ﹤0.01% | 5510 |
|
|
2024
Q1 | $38.8K | Buy |
2,901
+2,312
| +393% | +$30.9K | ﹤0.01% | 5379 |
|
|
2023
Q4 | $9.19K | Sell |
589
-107
| -15% | -$1.67K | ﹤0.01% | 5547 |
|
|
2023
Q3 | $16K | Sell |
696
-1,601
| -70% | -$36.8K | ﹤0.01% | 5355 |
|
|
2023
Q2 | $64.3K | Buy |
2,297
+1,538
| +203% | +$43.1K | ﹤0.01% | 4910 |
|
|
2023
Q1 | $26.7K | Sell |
759
-1,534
| -67% | -$54K | ﹤0.01% | 5333 |
|
|
2022
Q4 | $63.3K | Buy |
+2,293
| New | +$63.3K | ﹤0.01% | 5197 |
|
|
2022
Q3 | – | Sell |
-595
| Closed | -$28K | – | 6502 |
|
|
2022
Q2 | $28K | Buy |
+595
| New | +$28K | ﹤0.01% | 5651 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6935 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6990 |
|
|
2021
Q3 | – | Sell |
-1,409
| Closed | -$138K | – | 6929 |
|
|
2021
Q2 | $138K | Sell |
1,409
-1,827
| -56% | -$179K | ﹤0.01% | 5794 |
|
|
2021
Q1 | $267K | Buy |
+3,236
| New | +$267K | ﹤0.01% | 5150 |
|
|
2020
Q3 | – | Sell |
-1,802
| Closed | -$400K | – | 5132 |
|
|
2020
Q2 | $400K | Buy |
+1,802
| New | +$400K | ﹤0.01% | 3604 |
|
|
2019
Q1 | – | Sell |
-194
| Closed | -$26K | – | 4904 |
|
|
2018
Q4 | $26K | Buy |
+194
| New | +$26K | ﹤0.01% | 4206 |
|
|
2017
Q3 | – | Sell |
-56
| Closed | -$17K | – | 4002 |
|
|
2017
Q2 | $17K | Buy |
56
+5
| +10% | +$1.52K | ﹤0.01% | 3540 |
|
|
2017
Q1 | $20K | Buy |
+51
| New | +$20K | ﹤0.01% | 3520 |
|
|
2016
Q3 | – | Sell |
-129
| Closed | -$80K | – | 3936 |
|
|
2016
Q2 | $80K | Buy |
+129
| New | +$80K | ﹤0.01% | 2996 |
|